By Megan Wood
Here are eight things for spinal surgeons to know for Nov. 19, 2015.
Spinal fusions with BMP may not increase cancer risk
Researchers at Epworth Hospital in Melbourne, Victoria, Australia, contested the theory that recombinant human bone morphogenetic used in spinal fusion surgeries increases patients’ risk of cancer. In their study, at a follow-up of 4.4 years, 27 of the 527 patients were diagnosed with invasive cancer. This statistic did not differ significantly from the cancer registry’s number observed in a population of the same age and sex.